Search for information about a product,
therapeutic area or event

Media, investors, advocacy organizations and others, please contact us here.

Events Nephrology FSGS

15th International Podocyte Conference and 2025 ISGD Meeting

June 10 - 13, 2025

Germany

Events Nephrology Alport syndrome

62nd European Renal Association (ERA) Congress 2025

June 6 - 7, 2025

Austria

Posters Nephrology FSGS

Patients in DUPLEX Achieved Partial or Complete Remission of Proteinuria Earlier and More Often With Sparsentan vs Irbesartan: Implications for Slowing Progression to Kidney Failure in Focal Segmental Glomerulosclerosis (FSGS)

Posters Nephrology IgAN

Implications of Proteinuria Remission on Estimated Glomerular Filtration Rate Trajectory in Patients With IgA Nephropathy in PROTECT

Events Nephrology FSGS

American Nephrology Nurses Association (ANNA) National Symposium 2025

May 1 - 4, 2025

OR

Posters Nephrology IgAN

Improving Proteinuria With Sparsentan (SPAR) in Patients With IgA Nephropathy (IgAN): A Case Series 

Events Nephrology FSGS

National Kidney Foundation (NKF) Spring Clinical Meetings 2025

April 10 - 13, 2025

Boston

Publications Nephrology FSGS

Sparsentan Clinical Trials in Glomerular Diseases: Defining Endpoints and a Path Forward in Light of the Parasol Initiative

Events Nephrology IgAN

World Congress of Nephrology (WCN) 2025

February 6 - 9, 2025

India

Posters Nephrology IgAN

PROTECT Subgroup Analysis: Sparsentan Provides Clinical Benefits vs Irbesartan in Patients With IgA Nephropathy With Proteinuria Above and Below 1 g/g

Posters Nephrology IgAN

Sparsentan as First-Line Treatment of Incident Patients With IgA Nephropathy (IgAN): Interim Analysis of the SPARTAN Trial

Publications Nephrology IgAN

The Humanistic Burden of Immunoglobulin A Nephropathy on Patients and Care-Partners in the United States

Posters Nephrology IgAN

Concomitant Sparsentan and Sodium-Glucose Cotransporter-2 Inhibitors in Adults With IgA Nephropathy in the Ongoing Phase 2 SPARTACUS Trial